Printer Friendly

ROUSSEL UCLAF ANNOUNCES EXPECTED ACQUISITION OF ENVIRONMENTAL HEALTH DIVISION OF WELLCOME FOUNDATION, LTD.

            ROUSSEL UCLAF ANNOUNCES EXPECTED ACQUISITION OF
       ENVIRONMENTAL HEALTH DIVISION OF WELLCOME FOUNDATION, LTD.
    ENGLEWOOD, N.J., Nov. 12 /PRNewswire/ -- Roussel UCLAF has announced its intention to acquire the international Environmental Health business of the Wellcome Foundation, Ltd.
    Negotiations for Roussel UCLAF's acquisition of Environmental Health, which operates in the United States as Fairfield American Corporation, Rutherford, N.J., have entered the "due diligence" phase.
    In the United States, Roussel Bio Corporation, a wholly owned subsidiary of Roussel UCLAF, would merge with Fairfield American, a manufacturer and marketer of pesticides for the professional pest control, public health and concentrate markets.  The new organization will place itself in a position to better serve the needs of customers within its markets.
    Roussel Bio Corporation is a national manufacturer and supplier of insecticides, and marketer of branded specialty chemical products for the professional pest control and consumer lawn and garden markets.
    /delval/
    -0-                         11/12/91
    /CONTACT:  Michael Blash of The Dudnyk Company, 215-443-9406, for Roussel Bio Corporation/ CO:  Roussel UCLAF; Wellcome Foundation, Ltd.; Fairfield American
     Corporation; Roussel Bio Corporation ST:  New Jersey IN:  CHM SU:  TNM CC-KA -- PH039 -- 3588 11/12/91 15:59 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 12, 1991
Words:192
Previous Article:'THE LOOTERS' STARTS PRODUCTION
Next Article:ITALIAN COURT GRANTS RESTRAINING ORDER AGAINST CREDIT LYONNAIS
Topics:


Related Articles
ECOGEN SIGNS RESEARCH AND DEVELOPMENT AGREEMENT WITH ROUSSEL-UCLAF, THE INSTITUT PASTEUR AND INRA
ECOGEN TO MARKET ITS FIRST BIOPESTICIDE IN EASTERN EUROPE COMPANY RECEIVES MARKETING APPROVAL IN ROMANIA
IMMUNOGEN, INC. REGAINS EUROPEAN RIGHTS TO ONCOLYSIN B FROM ROUSSEL-UCLAF
ECOGEN BIOINSECTICIDE PRODUCTS REGISTERED IN CHINA; APPROVAL IS COMPANY'S FIRST IN CHINA, AN OVER $350 MILLION MARKET
FIRST REGISTRATIONS FOR ECOGEN PRODUCTS IN FRANCE; MARKETING APPROVAL FOR TWO BIOINSECTICIDES
REGISTRATION FOR ECOGEN BT PRODUCT IN AUSTRALIA; COMPANY STRENGTHENS INTERNATIONAL PRESENCE WITH NEW PRODUCT REGISTRATION
HOECHST CELANESE ANNOUNCES REALIGNMENT
Hoechst Pakistan Limited.
Good Start to 1997 After Weak Fourth Quarter of 1996
Vertex and Hoechst Marion Roussel Announce Start of Clinical Trial with HMR 3480/VX-740, a Novel Compound for Treatment of Inflammatory Diseases.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters